← All trials
NCT05462613
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2022
- Primary completion
- Nov 30, 2029
- Completion date
- Nov 30, 2030
- First posted
- Jul 18, 2022
- Last posted
- Jul 18, 2022
- Enrollment
- 446
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Franche-ComtéLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.